Kalkine has a fully transformed New Avatar.

Last update at 2026-03-10T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Business Process Outsourcing & Consulting Stocks Q1 Recap: Benchmarking CBIZ (NYSE:CBZ)
Tue 20 May 25, 03:32 AM3 Services Stocks Showing Warning Signs
Thu 15 May 25, 04:39 AM3 High-Flying Stocks with Questionable Fundamentals
Tue 13 May 25, 04:38 AMExponent First Quarter 2025 Earnings: Beats Expectations
Mon 12 May 25, 11:09 AMA Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)
Sun 04 May 25, 02:07 PMExponent Inc (EXPO) Q1 2025 Earnings Call Highlights: Navigating Flat Revenues and Strategic ...
Fri 02 May 25, 07:17 AMExponent Reports First Quarter 2025 Financial Results
Thu 01 May 25, 08:05 PM| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Income before tax | 132.23M | 125.84M | 96.94M | 104.19M | 93.32M |
| Minority interest | - | - | - | - | - |
| Net income | 102.33M | 101.20M | 82.55M | 82.46M | 72.25M |
| Selling general administrative | 287.89M | 293.33M | 262.93M | 272.72M | 232.58M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 478.21M | 433.68M | 399.90M | 391.39M | 354.64M |
| Reconciled depreciation | 7.08M | 6.49M | 6.87M | 6.81M | 6.29M |
| Ebit | 133.76M | 102.44M | 76.38M | 78.31M | 85.16M |
| Ebitda | 140.84M | 108.93M | 83.25M | 85.11M | 91.46M |
| Depreciation and amortization | 7.08M | 6.49M | 6.87M | 6.81M | 6.29M |
| Non operating income net other | - | - | 13.69M | 19.08M | 1.86M |
| Operating income | 140.84M | 108.93M | 83.25M | 85.11M | 91.46M |
| Other operating expenses | 372.45M | 357.34M | 316.65M | 332.09M | 288.07M |
| Interest expense | 2.10M | 23.40M | 20.56M | 25.89M | 1.86M |
| Tax provision | 29.90M | 24.64M | 14.38M | 21.73M | 21.06M |
| Interest income | 2.10M | 0.07M | 1.71M | 3.91M | 2.75M |
| Net interest income | 2.10M | 0.07M | 1.71M | 3.91M | 2.75M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 29.90M | 24.64M | 14.38M | 21.73M | 21.06M |
| Total revenue | 513.29M | 466.27M | 399.90M | 417.20M | 379.52M |
| Total operating expenses | 372.45M | 357.34M | 316.65M | 332.09M | 288.07M |
| Cost of revenue | 35.08M | 32.59M | - | 25.81M | 24.88M |
| Total other income expense net | -8.60800M | 16.91M | 13.69M | 19.08M | -0.89000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 102.33M | 101.20M | 82.55M | 82.46M | 72.25M |
| Net income applicable to common shares | 102.33M | 101.20M | 82.55M | 82.46M | 72.25M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 |
| Total assets | 662.32M | 586.66M | 683.74M | 580.10M | 563.41M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 25.02M | 17.59M | 15.21M | 12.74M | 12.30M |
| Total liab | 306.24M | 265.91M | 266.67M | 218.60M | 213.16M |
| Total stockholder equity | 356.08M | 320.75M | 417.06M | 361.50M | 350.25M |
| Deferred long term liab | - | - | - | 83.96M | 68.37M |
| Other current liab | 129.41M | 105.82M | 103.55M | 83.19M | 86.72M |
| Common stock | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M |
| Capital stock | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M |
| Retained earnings | 574.08M | 528.81M | 478.37M | 421.81M | 384.67M |
| Other liab | - | 93.54M | 103.89M | 86.95M | 71.04M |
| Good will | 8.61M | 8.61M | 8.61M | 8.61M | 8.61M |
| Other assets | - | 145.35M | 148.03M | 125.51M | 106.17M |
| Cash | 187.15M | 161.46M | 297.69M | 197.53M | 176.44M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 161.91M | 159.03M | 152.98M | 117.31M | 123.96M |
| Current deferred revenue | 21.71M | 18.83M | 19.76M | 11.80M | 12.71M |
| Net debt | -158.88900M | -142.85700M | -282.71600M | -177.19500M | -152.33400M |
| Short term debt | 6.30M | 5.26M | 5.16M | 5.99M | 5.94M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 28.26M | 18.60M | 14.97M | 20.33M | 24.10M |
| Other stockholder equity | -215.08600M | -204.53700M | -59.38800M | -58.44500M | -32.72300M |
| Property plant equipment | - | 83.55M | 74.34M | 59.82M | 61.59M |
| Total current assets | 379.53M | 349.16M | 452.76M | 366.83M | 364.04M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | 312.14M | 408.46M | 352.89M | 341.64M |
| Short term investments | - | - | 0.00000M | 45.00M | 55.16M |
| Net receivables | 167.36M | 170.11M | 139.86M | 111.56M | 120.14M |
| Long term debt | - | - | - | - | - |
| Inventory | 0.00000M | - | - | - | - |
| Accounts payable | 4.49M | 29.11M | 24.50M | 16.33M | 18.58M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -2.97700M | -3.58700M | -1.98300M | -1.93200M | -1.76000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 0.07M | 0.07M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | 421.81M | 384.67M |
| Treasury stock | - | - | - | -323.77300M | -277.65800M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 158.72M | 91.44M | 148.03M | 125.51M | 106.17M |
| Deferred long term asset charges | - | - | - | - | 36.82M |
| Non current assets total | 282.79M | 237.50M | 230.98M | 213.26M | 199.37M |
| Capital lease obligations | 28.26M | 18.60M | 14.97M | 20.33M | 24.10M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Investments | -12.04300M | 45.00M | 10.01M | 27.31M | -9.52200M |
| Change to liabilities | 1.29M | 16.41M | 1.92M | 18.61M | 6.06M |
| Total cashflows from investing activities | -12.04300M | 38.18M | 5.02M | 4.27M | -25.82000M |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -215.97700M | -62.75300M | -88.35500M | -63.41400M | -62.50000M |
| Change to operating activities | 0.36M | 15.52M | -4.60400M | 8.75M | -1.22700M |
| Net income | 102.33M | 101.20M | 82.55M | 82.46M | 72.25M |
| Change in cash | -136.22900M | 100.16M | 21.09M | 49.38M | 2.27M |
| Begin period cash flow | 297.69M | 197.53M | 176.44M | 127.06M | 124.79M |
| End period cash flow | 161.46M | 297.69M | 197.53M | 176.44M | 127.06M |
| Total cash from operating activities | 93.81M | 124.57M | 103.31M | 108.06M | 91.19M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 7.08M | 6.49M | 6.87M | 6.81M | 6.29M |
| Other cashflows from investing activities | - | - | - | 27.31M | -9.52200M |
| Dividends paid | -49.23700M | -43.19800M | -39.77500M | -33.50300M | 27.22M |
| Change to inventory | - | 15.93M | -4.51300M | 8.55M | -1.22700M |
| Change to account receivables | -33.33400M | -30.25400M | 6.72M | -16.54800M | 2.44M |
| Sale purchase of stock | -155.85600M | -7.00000M | -40.04900M | -21.95700M | -27.91500M |
| Other cashflows from financing activities | -10.88400M | -12.55500M | -8.53100M | -7.95400M | -7.36500M |
| Change to netincome | 16.08M | 15.21M | 15.49M | 16.84M | 15.13M |
| Capital expenditures | 12.04M | 6.83M | 4.99M | 23.04M | 16.30M |
| Change receivables | - | - | 6.72M | -16.54800M | 2.44M |
| Cash flows other operating | - | - | -10.07600M | 0.41M | -10.87200M |
| Exchange rate changes | - | - | - | - | -0.60300M |
| Cash and cash equivalents changes | - | - | 19.98M | 48.91M | 2.27M |
| Change in working capital | -31.68400M | 1.67M | -1.43600M | 2.46M | -2.54500M |
| Stock based compensation | 20.36M | 19.26M | 17.28M | 17.47M | 16.99M |
| Other non cash items | 3.08M | 1.95M | 1.69M | 1.71M | 1.91M |
| Free cash flow | 81.76M | 117.74M | 98.33M | 85.02M | 74.89M |
Sector: Industrials Industry: Engineering & Construction
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| EXPO Exponent Inc |
-1.63 2.27% | 70.25 | 48.82 | 42.55 | 7.97 | 11.13 | 7.09 | 31.64 |
| VCISF VINCI SA |
- -% | 167.75 | 14.66 | 12.94 | 1.06 | 2.37 | 1.40 | 8.24 |
| VCISY Vinci SA ADR |
0.02 0.05% | 37.77 | 14.51 | 12.97 | 1.07 | 2.38 | 1.40 | 8.26 |
| LTOUF Larsen & Toubro Limited |
- -% | 41.00 | 40.39 | 28.41 | 0.03 | 6.23 | 0.03 | 0.25 |
| PWR Quanta Services Inc |
-3.99 0.70% | 564.05 | 45.64 | 24.88 | 1.58 | 5.17 | 1.79 | 20.64 |
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
149 Commonwealth Drive, Menlo Park, CA, United States, 94025
| Name | Title | Year Born |
|---|---|---|
| Dr. Catherine Ford Corrigan P.E., Ph.D. | Pres, CEO & Director | 1969 |
| Mr. Richard L. Schlenker Jr. | Exec. VP, CFO & Corp. Sec. | 1966 |
| Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E. | Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director | 1969 |
| Dr. Steven J. Murray P.E., Ph.D. | Group VP & Principal Engineer | 1975 |
| Dr. Bernard Ross P.E., Ph.D. | Co-Founder, Chairman Emeritus & Principal Engineer | NA |
| Dr. Subbaiah V. Malladi P.E., Ph.D. | CTO & Principal Engineer | 1947 |
| Ms. Sally B. Shepard | Chief HR Officer | 1961 |
| Mr. Eric R. Anderson | VP & Corp. Controller | NA |
| Dr. Robert D. Caligiuri FASM, P.E., Ph.D. | Corp. VP of Materials & Corrosion Engineering and Principal Engineer | 1952 |
| Dr. Paul D. Boehm Ph.D. | Corp. VP of Environmental & Health Sciences and Principal Scientist | 1949 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.